关键词: fistula hemodialysis patency surgery vascular access

来  源:   DOI:10.3389/fsurg.2022.1079291   PDF(Pubmed)

Abstract:
UNASSIGNED: It is currently unclear if the anastomosis technique impacts the patency of upper arm arteriovenous fistula (AVF) in hemodialysis patients. This review compared outcomes of end-to-side and side-to-side anastomosis for AVF fistula in hemodialysis patients.
UNASSIGNED: PubMed, CENTRAL, Web of Science, and Embase were searched for all types of studies published between 1st January 2000 to 3rd September 2022. Patency rates at 6, 12 months, maturation time, and complications were compared between ETS and STS groups.
UNASSIGNED: Sixteen studies including six randomized controlled trials (RCTs) were included. Meta-analysis showed no difference in patency rates between ETS and STS group at 6 months (OR: 1.15 95% CI: 0.72, 1.83 I 2 = 52% p = 0.56) but better patency with STS at 12 months (OR: 0.63 95% CI: 0.41, 0.95 I 2 = 21% p = 0.03). The difference was non-significant in a subgroup analysis of RCTs and non-RCTs. In the absence of distal vein ligation in the STS group, the ETS group had significantly better patency at 6 months but with distal vein ligation, STS had higher patency at 12 months. Meta-analysis demonstrated no difference in maturation time between the two groups (MD: 0.10 95% CI: 0.29, 0.49 I 2 = 89% p = 0.61). Only a descriptive analysis of complications could be carried out with no major difference.
UNASSIGNED: Our review demonstrates that the STS anastomosis technique with distal vein ligation may result in significantly better patency rates as compared to the standard ETS technique. Data for complication rates are scarce and varied but without any significant differences between the two techniques.
摘要:
UNASSIGNED:目前尚不清楚吻合技术是否会影响血液透析患者上臂动静脉瘘(AVF)的通畅。这篇综述比较了端对侧和侧对侧吻合治疗血液透析患者AVF瘘的结果。
未经授权:PubMed,中部,WebofScience,和Embase检索了2000年1月1日至2022年9月3日之间发表的所有类型的研究。6、12个月的通畅率,成熟时间,比较ETS和STS组的并发症。
UNASSIGNED:纳入了16项研究,包括6项随机对照试验(RCTs)。Meta分析显示,ETS组和STS组6个月的通畅率无差异(OR:1.1595%CI:0.72,1.83I2=52%p=0.56),但STS组12个月的通畅率更好(OR:0.6395%CI:0.41,0.95I2=21%p=0.03)。在RCT和非RCT的亚组分析中,差异无统计学意义。在STS组没有远端静脉结扎的情况下,ETS组在6个月时的通畅性明显更好,但远端静脉结扎,STS在12个月时通畅率较高。Meta分析显示两组间成熟时间无差异(MD:0.1095%CI:0.29,0.49I2=89%p=0.61)。只能对并发症进行描述性分析,没有重大差异。
UNASSIGNED:我们的审查表明,与标准ETS技术相比,采用远端静脉结扎的STS吻合技术可能会导致更好的通畅率。并发症发生率的数据很少且各不相同,但两种技术之间没有任何显着差异。
公众号